Home Altum Sequencing

Altum Sequencing

Altum Sequencing

Altum Sequencing
Category
Business Description
Altum Sequencing is a spin-off of Hospital 12 de octubre with a patented ultra-sensitivity technology to monitor oncology patients using liquid biopsy.
Long Business Description

Altum Sequencing is a biotechnology company specializing in non-invasive products to detect tumor cells that survive therapy. Founded in 2019 by doctors and researchers from the Hospital 12 de Octubre in Madrid. Its objective is to introduce personalized tests into clinical practice that allow the monitoring of cancer patients and selecting the best treatment. Their versatility, applicability, and competitive price place them in a privileged position in an emerging market with high social impact.

Based in
Madrid
Tags
liquid biopsy, minimal residual disease, NGS,oncology.
Total Funding
Between €100K-€500K
Founded
2019
Website
www.altumsequencing.com
💡 You're a corporate or investor and looking for startups that are innovating in the same market as Altum Sequencing? We're happy to assist you with our Startup Sourcing service.